These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 15163435)

  • 1. Elevation of the cortisol/dehydroepiandrosterone ratio in schizophrenia patients.
    Ritsner M; Maayan R; Gibel A; Strous RD; Modai I; Weizman A
    Eur Neuropsychopharmacol; 2004 Aug; 14(4):267-73. PubMed ID: 15163435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. State and trait related predictors of serum cortisol to DHEA(S) molar ratios and hormone concentrations in schizophrenia patients.
    Ritsner M; Gibel A; Maayan R; Ratner Y; Ram E; Modai I; Weizman A
    Eur Neuropsychopharmacol; 2007 Mar; 17(4):257-64. PubMed ID: 17107774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulatory neurosteroid levels in smoking and non-smoking chronic schizophrenia patients.
    Iancu I; Tchernihovsky E; Maayan R; Poreh A; Dannon P; Kotler M; Weizman A; Strous RD
    Eur Neuropsychopharmacol; 2007 Jul; 17(8):541-5. PubMed ID: 17346944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations in DHEA metabolism in schizophrenia: two-month case-control study.
    Ritsner M; Gibel A; Ram E; Maayan R; Weizman A
    Eur Neuropsychopharmacol; 2006 Feb; 16(2):137-46. PubMed ID: 16139994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cortisol/dehydroepiandrosterone ratio and responses to antipsychotic treatment in schizophrenia.
    Ritsner M; Gibel A; Maayan R; Ratner Y; Ram E; Biadsy H; Modai I; Weizman A
    Neuropsychopharmacology; 2005 Oct; 30(10):1913-22. PubMed ID: 15870835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurocognitive deficits in schizophrenia are associated with alterations in blood levels of neurosteroids: a multiple regression analysis of findings from a double-blind, randomized, placebo-controlled, crossover trial with DHEA.
    Ritsner MS; Strous RD
    J Psychiatr Res; 2010 Jan; 44(2):75-80. PubMed ID: 19665142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum cortisol and dehydroepiandrosterone-sulfate levels in schizophrenic patients and their first-degree relatives.
    Yıldırım O; Dogan O; Semiz M; Kilicli F
    Psychiatry Clin Neurosci; 2011 Oct; 65(6):584-91. PubMed ID: 21895860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased levels of nitric oxide, cortisol and adrenomedullin in patients with chronic schizophrenia.
    Yilmaz N; Herken H; Cicek HK; Celik A; Yürekli M; Akyol O
    Med Princ Pract; 2007; 16(2):137-41. PubMed ID: 17303950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in blood pregnenolone and dehydroepiandrosterone levels between schizophrenia patients and healthy subjects.
    Ritsner M; Maayan R; Gibel A; Weizman A
    Eur Neuropsychopharmacol; 2007 Apr; 17(5):358-65. PubMed ID: 17123790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulatory neurosteroid levels in underweight female adolescent anorexia nervosa inpatients and following weight restoration.
    Stein D; Maayan R; Ram A; Loewenthal R; Achiron A; Modan-Moses D; Feigin M; Weizman A; Valevski A
    Eur Neuropsychopharmacol; 2005 Dec; 15(6):647-53. PubMed ID: 16023331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Negative correlation between negative symptoms of schizophrenia and testosterone levels.
    Goyal RO; Sagar R; Ammini AC; Khurana ML; Alias AG
    Ann N Y Acad Sci; 2004 Dec; 1032():291-4. PubMed ID: 15677432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of mirtazapine on dehydroepiandrosterone-sulfate and cortisol plasma concentrations in depressed patients.
    Schüle C; Baghai TC; Eser D; Schwarz M; Bondy B; Rupprecht R
    J Psychiatr Res; 2009 Feb; 43(5):538-45. PubMed ID: 18706658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Difference in pre- and post-treatment plasma DHEA levels were significantly and positively correlated with difference in pre- and post-treatment Hamilton depression scores following successful therapy for major depression.
    Hsiao CC
    Psychoneuroendocrinology; 2006 Aug; 31(7):839-46. PubMed ID: 16716529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dehydroepiandrosterone augmentation in the management of negative, depressive, and anxiety symptoms in schizophrenia.
    Strous RD; Maayan R; Lapidus R; Stryjer R; Lustig M; Kotler M; Weizman A
    Arch Gen Psychiatry; 2003 Feb; 60(2):133-41. PubMed ID: 12578430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Negative symptoms, depression, anxiety and alexithymia in DSM III-R schizophrenic patients].
    Nkam I; Langlois-Thery S; Dollfus S; Petit M
    Encephale; 1997; 23(4):267-72. PubMed ID: 9417392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positive family history is associated with persistent elevated emotional distress in schizophrenia: evidence from a 16-month follow-up study.
    Ritsner MS; Ratner Y; Gibel A; Weizman R
    Psychiatry Res; 2007 Dec; 153(3):217-23. PubMed ID: 17675246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gender differences in susceptibility to schizophrenia: Potential implication of neurosteroids.
    Huang YC; Hung CF; Lin PY; Lee Y; Wu CC; Hsu ST; Chen CC; Chong MY; Lin CH; Wang LJ
    Psychoneuroendocrinology; 2017 Oct; 84():87-93. PubMed ID: 28686904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Alexithymia in negative symptom and non-negative symptom schizophrenia].
    Nkam I; Langlois-Thery S; Dollfus S; Petit M
    Encephale; 1997; 23(5):358-63. PubMed ID: 9453928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum cortisol and DHEA-S levels in schizophrenic patients with different response to antipsychotic therapy: association with psychopathology.
    Babinkostova Z; Stefanovski B; Janicevic-Ivanovska D; Samardziska V; Stojanovska L
    Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2015; 36(1):175-83. PubMed ID: 26076787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum levels of brain-derived neurotrophic factor and cortisol to sulfate of dehydroepiandrosterone molar ratio associated with clinical response to L-theanine as augmentation of antipsychotic therapy in schizophrenia and schizoaffective disorder patients.
    Miodownik C; Maayan R; Ratner Y; Lerner V; Pintov L; Mar M; Weizman A; Ritsner MS
    Clin Neuropharmacol; 2011; 34(4):155-60. PubMed ID: 21617527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.